Biotech

All Articles

' Medical intuitiveness' led FDA advisors to back Zevra's rare illness med

.Zevra Rehabs' uncommon illness medication seems to be on the pathway to confirmation this loss afte...

Pfizer takes $230M hit after axing neglected DMD gene therapy

.Pfizer's stage 3 Duchenne muscular dystrophy (DMD) genetics treatment failing has actually gone a $...

AC Immune observes 'landmark' potential in Alzheimer's drug data

.After more than twenty years of deal with neurodegenerative ailments, Swiss biotech air conditionin...

GSK drops ph. 2 HPV vaccination over lack of best-in-class prospective

.GSK has ditched a stage 2 individual papillomavirus (HPV) injection from its own pipeline after cho...

OS Treatments refiles $6M IPO to cash HER2 drug, preclinical ADCs

.Operating system Therapies will list on the NYSE American sell substitution today by means of a $6....

ALX's waning CD47 action cost sends out stock spiraling down

.ALX Oncology's phase 2 stomach cancer cells feedback rate has actually damaged. After finding its C...

Ionis centers eye illness coming from aim ats of Roche-partnered possibility after data let down

.An Additional of Ionis Pharmaceuticals' crucial midphase readouts has actually fallen short of expe...

Biogen's chief executive officer pointed out no unsafe sell 2023. He prepares to be bold

.While Biogen's pharma peers are actually hunting for late-stage resources along with little bit of ...

Instil refills pipeline in $2B biobucks deal with ImmunOnco

.Instil Bio has been actually a biotech in search of a pipe after it ditched its lead properties ove...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually returned liberties to a very early Alzheimer's illness plan to Denali Therapeut...